Trials for Alzheimer’s Drug Halted After Poor Results
Pfizer Inc. on Saturday said it would stop trying to discover new drugs for Alzheimer’s disease and Parkinson’s disease, abandoning costly but futile efforts to find effective treatments for the disorders.